Pivotal’s public equity team invests in publicly listed companies with innovative therapeutics, devices, or biomedical tools that are underappreciated by the market. We invest globally and primarily in the small- to mid-cap space. We leverage deep fundamental research and rigorous financial analysis to help select potentially undervalued companies, with a focus on opportunities with specific catalysts, in order to achieve attractive long-term risk adjusted returns.
Pivotal Public Equity
23F, 88 Connaught Road,
Nan Fung Tower Central,
Hong Kong SAR
Nan Fung Tower Central,
Hong Kong SAR
![Pivotal_Image_PE_550px](https://pivotallifesciences.com/wp-content/uploads/2023/10/Pivotal_Image_LisaCai_550px.jpg)